Trials / Completed
CompletedNCT03755661
MI With Text Messaging to Reduce Sexual Risk and Hazardous Drinking Among MSM
Alcohol and Implicit Process in Sexual Risk Behavior in MSM Supplement
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Boston University Charles River Campus · Academic / Other
- Sex
- Male
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a small pilot study to provide effect size estimates for a brief intervention designed to reduce hazardous drinking and sexual risk behavior among men who have sex with men. The intervention consists of an "in-person" brief motivational intervention followed by a series of text messages related to alcohol and sexual risk reduction. The primary outcome is heavy drinking episodes and frequency of condomless anal intercourse at 3 months.
Detailed description
This is a pilot study designed to provide initial effect size estimates for an intervention addressing hazardous drinking and sexual risk behavior among men who have sex with men. In this study, 24 participants initially recruited through advertisements in the community will be randomly assigned to either Assessment Only or Intervention Condition. Those in the Assessment Only condition will complete baseline, 6-week, 3-month and 6-month assessments. Those in the intervention condition will receive a 50-min brief intervention in person followed by 6 weeks of tailored app-based messaging to support the intervention content, then another 6-weeks of goal setting text-based messages. Data will be analyzed to determine effect sizes of the intervention on key alcohol use and sex risk outcomes. The primary outcome will be 3-month outcomes, controlling for corresponding baseline outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | MI&TXT4MSM | brief in-person intervention followed by text messaging |
Timeline
- Start date
- 2018-10-09
- Primary completion
- 2020-03-09
- Completion
- 2020-03-09
- First posted
- 2018-11-28
- Last updated
- 2021-05-06
- Results posted
- 2021-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03755661. Inclusion in this directory is not an endorsement.